Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)

Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)



Report Overview:

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.

Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.

The Global Biosimilar Monoclonal Antibody Market Size was estimated at USD 4695.37 million in 2023 and is projected to reach USD 5738.43 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.

This report provides a deep insight into the global Biosimilar Monoclonal Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilar Monoclonal Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilar Monoclonal Antibody market in any manner.

Global Biosimilar Monoclonal Antibody Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biocon

Accord Healthcare

AET Biotech

Amgen

Celltrion

Reddy's Laboratories

Hospira

3SBio

Allergan

Alvartis

Market Segmentation (by Type)

Limited Dilution Method

Micromanipulation

Soft Agar Plate Method

Others

Market Segmentation (by Application)

Chronic & Autoimmune Diseases

Oncology

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Biosimilar Monoclonal Antibody Market

Overview of the regional outlook of the Biosimilar Monoclonal Antibody Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilar Monoclonal Antibody Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biosimilar Monoclonal Antibody
1.2 Key Market Segments
1.2.1 Biosimilar Monoclonal Antibody Segment by Type
1.2.2 Biosimilar Monoclonal Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biosimilar Monoclonal Antibody Market Overview
2.1 Global Market Overview
2.1.1 Global Biosimilar Monoclonal Antibody Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biosimilar Monoclonal Antibody Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biosimilar Monoclonal Antibody Market Competitive Landscape
3.1 Global Biosimilar Monoclonal Antibody Sales by Manufacturers (2019-2024)
3.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biosimilar Monoclonal Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biosimilar Monoclonal Antibody Sales Sites, Area Served, Product Type
3.6 Biosimilar Monoclonal Antibody Market Competitive Situation and Trends
3.6.1 Biosimilar Monoclonal Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biosimilar Monoclonal Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biosimilar Monoclonal Antibody Industry Chain Analysis
4.1 Biosimilar Monoclonal Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biosimilar Monoclonal Antibody Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biosimilar Monoclonal Antibody Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biosimilar Monoclonal Antibody Sales Market Share by Type (2019-2024)
6.3 Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2019-2024)
6.4 Global Biosimilar Monoclonal Antibody Price by Type (2019-2024)
7 Biosimilar Monoclonal Antibody Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biosimilar Monoclonal Antibody Market Sales by Application (2019-2024)
7.3 Global Biosimilar Monoclonal Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global Biosimilar Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
8 Biosimilar Monoclonal Antibody Market Segmentation by Region
8.1 Global Biosimilar Monoclonal Antibody Sales by Region
8.1.1 Global Biosimilar Monoclonal Antibody Sales by Region
8.1.2 Global Biosimilar Monoclonal Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Biosimilar Monoclonal Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biosimilar Monoclonal Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biosimilar Monoclonal Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biosimilar Monoclonal Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biosimilar Monoclonal Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biocon
9.1.1 Biocon Biosimilar Monoclonal Antibody Basic Information
9.1.2 Biocon Biosimilar Monoclonal Antibody Product Overview
9.1.3 Biocon Biosimilar Monoclonal Antibody Product Market Performance
9.1.4 Biocon Business Overview
9.1.5 Biocon Biosimilar Monoclonal Antibody SWOT Analysis
9.1.6 Biocon Recent Developments
9.2 Accord Healthcare
9.2.1 Accord Healthcare Biosimilar Monoclonal Antibody Basic Information
9.2.2 Accord Healthcare Biosimilar Monoclonal Antibody Product Overview
9.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Product Market Performance
9.2.4 Accord Healthcare Business Overview
9.2.5 Accord Healthcare Biosimilar Monoclonal Antibody SWOT Analysis
9.2.6 Accord Healthcare Recent Developments
9.3 AET Biotech
9.3.1 AET Biotech Biosimilar Monoclonal Antibody Basic Information
9.3.2 AET Biotech Biosimilar Monoclonal Antibody Product Overview
9.3.3 AET Biotech Biosimilar Monoclonal Antibody Product Market Performance
9.3.4 AET Biotech Biosimilar Monoclonal Antibody SWOT Analysis
9.3.5 AET Biotech Business Overview
9.3.6 AET Biotech Recent Developments
9.4 Amgen
9.4.1 Amgen Biosimilar Monoclonal Antibody Basic Information
9.4.2 Amgen Biosimilar Monoclonal Antibody Product Overview
9.4.3 Amgen Biosimilar Monoclonal Antibody Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Celltrion
9.5.1 Celltrion Biosimilar Monoclonal Antibody Basic Information
9.5.2 Celltrion Biosimilar Monoclonal Antibody Product Overview
9.5.3 Celltrion Biosimilar Monoclonal Antibody Product Market Performance
9.5.4 Celltrion Business Overview
9.5.5 Celltrion Recent Developments
9.6 Reddy's Laboratories
9.6.1 Reddy's Laboratories Biosimilar Monoclonal Antibody Basic Information
9.6.2 Reddy's Laboratories Biosimilar Monoclonal Antibody Product Overview
9.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Product Market Performance
9.6.4 Reddy's Laboratories Business Overview
9.6.5 Reddy's Laboratories Recent Developments
9.7 Hospira
9.7.1 Hospira Biosimilar Monoclonal Antibody Basic Information
9.7.2 Hospira Biosimilar Monoclonal Antibody Product Overview
9.7.3 Hospira Biosimilar Monoclonal Antibody Product Market Performance
9.7.4 Hospira Business Overview
9.7.5 Hospira Recent Developments
9.8 3SBio
9.8.1 3SBio Biosimilar Monoclonal Antibody Basic Information
9.8.2 3SBio Biosimilar Monoclonal Antibody Product Overview
9.8.3 3SBio Biosimilar Monoclonal Antibody Product Market Performance
9.8.4 3SBio Business Overview
9.8.5 3SBio Recent Developments
9.9 Allergan
9.9.1 Allergan Biosimilar Monoclonal Antibody Basic Information
9.9.2 Allergan Biosimilar Monoclonal Antibody Product Overview
9.9.3 Allergan Biosimilar Monoclonal Antibody Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 Alvartis
9.10.1 Alvartis Biosimilar Monoclonal Antibody Basic Information
9.10.2 Alvartis Biosimilar Monoclonal Antibody Product Overview
9.10.3 Alvartis Biosimilar Monoclonal Antibody Product Market Performance
9.10.4 Alvartis Business Overview
9.10.5 Alvartis Recent Developments
10 Biosimilar Monoclonal Antibody Market Forecast by Region
10.1 Global Biosimilar Monoclonal Antibody Market Size Forecast
10.2 Global Biosimilar Monoclonal Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biosimilar Monoclonal Antibody Market Size Forecast by Country
10.2.3 Asia Pacific Biosimilar Monoclonal Antibody Market Size Forecast by Region
10.2.4 South America Biosimilar Monoclonal Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biosimilar Monoclonal Antibody by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biosimilar Monoclonal Antibody Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biosimilar Monoclonal Antibody by Type (2025-2030)
11.1.2 Global Biosimilar Monoclonal Antibody Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biosimilar Monoclonal Antibody by Type (2025-2030)
11.2 Global Biosimilar Monoclonal Antibody Market Forecast by Application (2025-2030)
11.2.1 Global Biosimilar Monoclonal Antibody Sales (K Units) Forecast by Application
11.2.2 Global Biosimilar Monoclonal Antibody Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings